RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to
release second quarter 2017 financial and operating results after the
market closes on Wednesday, August 2, 2017. Todd M. Pope, President and
Chief Executive Officer, and Joseph P. Slattery, Executive Vice
President and Chief Financial Officer will host a conference call to
discuss these results starting at 4:30 pm Eastern Time the same day. The
call will be concurrently webcast.
To listen to the conference call on your telephone, please dial
877-852-6561 for domestic callers and 719-325-2281 for international
callers, and reference TransEnterix Call approximately ten minutes prior
to the start time. To access the live audio webcast or archived
recording, use the following link http://ir.transenterix.com/events.cfm.
The replay will be available on the Company's website.
TransEnterix is a medical device company that is pioneering the use of
robotics to improve minimally invasive surgery by addressing the
clinical and economic challenges associated with current laparoscopic
and robotic options. The company is focused on the commercialization of
the Senhance Surgical Robotic System, a multi-port robotic system that
brings the advantages of robotic surgery to patients while enabling
surgeons with innovative technology such as haptic feedback and eye
sensing camera control. The company also developed the SurgiBot™ System,
a single-port, robotically enhanced laparoscopic surgical platform. The
Senhance Surgical Robotic System has been granted a CE Mark and is
currently under FDA 510(k) review for clearance in the United States.
For more information, visit the TransEnterix website at www.transenterix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170713005035/en/
For TransEnterix, Inc.
(For EU) Conrad Harrington, +44 (0)20 3178 8914
US) Hannah Dunning, +1 415-618-8750
Source: TransEnterix, Inc.
News Provided by Acquire Media